Converging lines of evidence from basic science and clinical studies suggest a relationship
between maternal immune activation (MIA) and neurodevelopmental disorders such as …

Activation of the maternal immune system during pregnancy is a well-established risk factor
for neuropsychiatric disease in the offspring, yet, the underlying mechanisms leading to …

Epidemiological evidence implicates maternal infection as a risk factor for autism spectrum
disorder and schizophrenia. Animal models corroborate this link and demonstrate that …

Maternal immune activation (mIA) during pregnancy is hypothesised to disrupt offspring
neurodevelopment and predispose offspring to neurodevelopmental disorders such as …

Maternal immune activation (MIA) is mediated by activation of inflammatory pathways
resulting in increased levels of cytokines and chemokines that cross the placental and blood …

Epidemiological evidence suggests that one's risk of being diagnosed with a
neurodevelopmental disorder (NDD)—such as autism, ADHD, or schizophrenia—increases …

Growing evidence from epidemiological studies strongly suggests maternal infection as a
risk factor for psychiatric disorders including bipolar disorder, schizophrenia, and autism …

Exposure to maternal infection in utero increases the risk that offspring will develop
neurodevelopmental disorders such as autism spectrum disorder (ASD) and schizophrenia …

Maternal immune activation (MIA) at the time of gestation has been linked to increased risk
of neurodevelopmental psychiatric disorders. Animal and human models have been used to …

Maternal infection or inflammation causes abnormalities in brain development associated
with subsequent cognitive impairment and in an increased susceptibility to schizophrenia …